Localized well-differentiated thyroid carcinoma: Survival analysis of prognostic factors and 131I therapy

Annals of Surgical Oncology

Volumn 5, Issue 4, 1998, Pages 329-337

  Morris, Don M ^a,b   Boyle, Patrick J ^b   Stidley, Christine A ^a,b,c   Altobelli, Kathleen K ^a,c   Parnell, Teresa ^d   Key, Charles ^a,b,c  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF NEW MEXICO HOSPITAL   (United States)

Author keywords

131I; Prognostic factors; Survival; Thyroid cancer; Well differentiated

Indexed keywords

IODINE 131;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PROGNOSIS; SEX DIFFERENCE; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; CHILD; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEW MEXICO; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0031777474     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303496     Document Type: Article

References (33)

1. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
2. Samaan NA, Schnitz PN, Hickey RC, el al. Well-differentiated thyroid carcinoma and the results of various modalities of treatment. A retrospective review of 1599 patients. J Clin Endocrinol Metab 1992;75:714-20.
3. 131 I ablation following thyroidectomy in patients with invasive follicular thyroid cancer. Am J Surg 1992;163:472-5.
4. Woolner LB,Lemmon ML, Beahrs OH, Black BM, Keating FR Jr. Occult papillary carcinoma of the thyroid gland: a study of 100 cases observed in a 30-year period. J Clin Endocrinol Metab 1960; 20:89-105.
5. Beierwaltes WH. The treatment of thyroid carcinoma with radioactive iodine. Semin Nucl Med 1978;1:79-94.
6. Wingo PA, Tong T, Bolden BA. Cancer statistics, 1995. CA Cancer J Clin 1995;45:8-30.
7. Wong JB, Kaplan MM, Meyer KB, Pauker SG. Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. Endocrinol Metab Clin North Am 1990;19:741-60.
8. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: John Wiley, 1980.
9. SAS Institute, lnc, SAS User's Guide: Statistics, version 6. Cary, NC: SAS Institute, 1990.
10. Beierwaltes WH, Nishiyama RH. Thompson NW, et al. Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy. J Nucl Med 1982;23:561-8.
11. Synder J, Gorman C, Scanlon P. Thyroid remnant ablation: questionable pursuit of an ill-defined goal. J Nucl Med 1983;24:659-65.
12. Mazzaferri EL, Young RL, Oertel JE, et al. Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine 1997;56: 171-96.
13. Young RL, Mazzferri EL, Rahe AJ, Dorfman SG. Pure follicular thyroid carcinoma: impact of therapy in 214 patients. J Nucl Med 1980;21:733-7.
14. Joensuu H, Klemi PJ, Paul F, Tuominen J. Survival and prognostic factors in thyroid carcinoma. Acta Radial Oncol 1986;25:243-8.
15. Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:749-804.
16. Torres J, Volpato RD, Power EG, et al. Thyroid cancer-survival in 148 cases followed for ten years or more. Cancer 1985;56:2298-2304.
17. Cunningham MP, Duda RB, Recant W, et al. Survival discriminates for differentiated thyroid cancer. Am J Surg 1990;160:344-7.
18. McHenry C, Jarosz H, Lawrence AM, Paloyan E. Improving post-operative recurrence rates for carcinoma of the thyroid gland. Surg Gynecol Obstet 1969;169:429-34.
19. Grant CS, Hay ID, Gough IR, et al. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 1988;104:954-61.
20. Leeper RD. Thyroid cancer. Med Clin North Am 1985;69:1079-96.
21. Maxon HR III, Smith HS. Radioiodine-131 in the diagnosis and treatment of metastatic well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 1990;19:685-90.
22. DeGroot J, Reilly M. Comparison of 30 and 50 m Ci doses of iodine-131 for thyroid ablation. Ann Int Med 1982;96:51-3.
23. McCowen KD, Adler RA, Ghaed N, et al. Low dose radioiodine thyroid ablation in post surgical patients with thyroid cancer. Am J Med 1976;61:52-8.
24. Nemed J, Rohling S, Zamrazil V, et al. Comparison of the distribution of diagnostic and thyroablative I-131 in the evaluation of differentiated thyroid cancer. J Nucl Med 1979;20:92-7.
25. Krishnamurthy GT, Blahd WH. Radioiodine I131 therapy in the management of thyroid cancer. A prospective study. Cancer 1977; 40:195-202.
26. Verma VM, Beierwaltes WH, Nofal NM. et al. Treatment of thyroid cancer: death rates after surgery and after surgery followed by sodium iodide I-131. JAMA 1970;214:1437-42.
27. Maxon HR, Thomas SR, Chen I-W. The role of nuclear medicine in the treatment of hyperthyroidism and well-differentiated thyroid adenocarcinoma. Clin Nucl Med 1981;6:87-98.
28. Golden AW, Darey JB. The ablation of normal thyroid tissue with iodine 131. Br J Radiol 1963;36:340-5.
29. Becker DV, Hurley JR, Motazedi A, Cahill PT. Ablation of post-surgical thyroid remnants in patients with differentiated thyroid cancer can be achieved with less whole body radiation. (Abstract). J Nucl Med 1982;23:P43.
30. Doniach I. Effects of radiation on thyroid function and structure. In: Greer MA, Solomon DH, eds. Handbook of Physiology. Section 7s. Vol. 3. Washington, DC: American Physiological Society. 1974:359-75.
31. Waxman A, Ramanna L. Chapman M, et al. The significance of I-131 scan dose in patients with thyroid cancer: determination of ablation. Concise communication. J Nucl Med 1981;22:861-5.
32. Pochin EE. Radioiodine therapy for thyroid carcinoma. Semin Nucl Med 1971:1:503-15.
33. Edmonds CJ, Hayes S, Kermode JC, el al. Measurement of serum TSH and thyroid hormones in the management of thyroid carcinoma with radioiodine. Br J Radiol 1977;50:799-807.